Drug Search Results
Using advanced filters...
Advanced Search [+]

Choline chloride

Alternative Names: choline chloride
Latest Update: 2025-04-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: mAChR Agonist,nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Injection

FDA Designation: Fast Track - Liver Failure *

Approval Status: Not Approved

Approved Countries: Australia | Bangladesh | Brazil | Chile | India | Ireland | Malta | Pakistan | South Africa | Sweden | Taiwan | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Protara Therapeutics
Company Location: NEW YORK NY 10010
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Choline Deficiency|Liver Failure

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

THRIVE-3

P3

Not yet recruiting

Liver Failure|Choline Deficiency

2027-06-01

Recent News Events